NCT07398248

Brief Summary

This randomized controlled trial aims to examine the effects of a weightlifting-based training program on hormonal, metabolic, and lipid profile parameters in athletes. Participants will be randomly assigned to either a weightlifting-based training group or a control group. The training program will be implemented for a specific period, and relevant blood parameters will be evaluated before and after the intervention. The findings of this study may contribute to a better understanding of the physiological effects of weightlifting-based training on athletes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
Last Updated

February 9, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

December 29, 2025

Last Update Submit

February 4, 2026

Conditions

Keywords

PowerliftingStrength TrainingBasketball

Outcome Measures

Primary Outcomes (6)

  • Mean Change in Fasting Serum Total Testosterone Concentration Measured by ELISA (ng/dL)

    Mean difference between baseline and post-intervention fasting serum total testosterone concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).

    Baseline and post-intervention (8 weeks)

  • Mean Change in Fasting Serum Cortisol Concentration Measured by ELISA (µg/dL)

    Mean difference between baseline and post-intervention fasting serum cortisol concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).

    Baseline and post-intervention (8 weeks)

  • Mean Change in Fasting Serum Growth Hormone Concentration Measured by ELISA (ng/mL)

    Mean difference between baseline and post-intervention fasting serum growth hormone concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).

    Baseline and post-intervention (8 weeks)

  • Mean Change in Fasting Serum Thyroid-Stimulating Hormone Concentration Measured by ELISA (µIU/mL)

    Mean difference between baseline and post-intervention fasting serum thyroid-stimulating hormone concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).

    Baseline and post-intervention (8 weeks)

  • Mean Change in Fasting Serum Triiodothyronine Concentration Measured by ELISA (ng/dL)

    Mean difference between baseline and post-intervention fasting serum triiodothyronine concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).

    Baseline and post-intervention (8 weeks)

  • Mean Change in Fasting Serum Thyroxine Concentration Measured by ELISA (µg/dL)

    Mean difference between baseline and post-intervention fasting serum thyroxine concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).

    Baseline and post-intervention (8 weeks)

Secondary Outcomes (6)

  • Mean Change in Fasting Serum Insulin Concentration Measured by ELISA (µIU/mL)

    Baseline and post-intervention (8 weeks)

  • Mean Change in Fasting Blood Glucose Concentration Measured by Automated Biochemical Analyzer (mg/dL)

    Baseline and post-intervention (8 weeks)

  • Mean Change in Total Cholesterol Concentration Measured by Automated Biochemical Analyzer (mg/dL)

    Baseline and post-intervention (8 weeks)

  • Mean Change in Low-Density Lipoprotein Cholesterol Concentration Measured by Automated Biochemical Analyzer (mg/dL)

    Baseline and post-intervention (8 weeks)

  • Mean Change in High-Density Lipoprotein Cholesterol Concentration Measured by Automated Biochemical Analyzer (mg/dL)

    Baseline and post-intervention (8 weeks)

  • +1 more secondary outcomes

Study Arms (2)

Powerlifting-Based Training Group

EXPERIMENTAL

Participants performed a structured powerlifting-based training program in addition to their regular basketball training. The intervention was conducted three days per week for six weeks. Each session lasted approximately 60 minutes and included a standardized warm-up, a powerlifting-focused main training phase, and a cool-down period. The training program emphasized the squat, bench press, and deadlift exercises performed with progressive intensity. Accessory exercises targeting lower-body strength, upper-body musculature, and core stability were included. High-intensity bodyweight exercises were also performed to enhance anaerobic capacity and neuromuscular performance. All training sessions were supervised by qualified staff.

Other: Powerlifting-Based TrainingOther: Blood Sampling and Laboratory Analysis

Control Group

OTHER

Participants continued their usual basketball training routines throughout the study period without any additional strength or powerlifting-based exercises.

Other: Usual Basketball TrainingOther: Blood Sampling and Laboratory Analysis

Interventions

Participants will perform a structured powerlifting-based training program including squat, bench press, and deadlift exercises, conducted 3 sessions per week for 8 weeks under supervision.

Powerlifting-Based Training Group

Participants continued their usual basketball training routines without any additional strength or powerlifting-based exercises.

Control Group

Venous blood samples were collected from participants at baseline and post-intervention following an overnight fast. Hormonal parameters were analyzed using ELISA methods, and metabolic and lipid profile parameters were analyzed using an automated biochemical analyzer.

Control GroupPowerlifting-Based Training Group

Eligibility Criteria

Age18 Years - 24 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsOnly male athletes were eligible to participate in this study.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male basketball players aged 18 to 24 years
  • At least two years of regular sports experience
  • Actively participating in basketball training and competition
  • Voluntary participation with written informed consent

You may not qualify if:

  • History of musculoskeletal injury or surgery within the last six months
  • Presence of chronic disease or metabolic disorder
  • Use of performance-enhancing drugs or hormonal supplements
  • Participation in another structured training program during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Sport Sciences

Tunceli, Center, 62000, Turkey (Türkiye)

Location

Munzur University

Bitlis, Tunceli, 62000, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 29, 2025

First Posted

February 9, 2026

Study Start

January 10, 2025

Primary Completion

June 15, 2025

Study Completion

October 15, 2025

Last Updated

February 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to ethical restrictions, participant confidentiality concerns, and the absence of participant consent for data sharing beyond the scope of this study.

Locations